Gadopentetate dimeglumine

From Wikipedia, the free encyclopedia

You have new messages (last change).
There are very few or no other articles that link to this one.
Please help introduce links in articles on related topics. After links have been created, remove this message.
This article has been tagged since September 2006.

Gadopentetate dimeglumine (Gd-DTPA) was the first paramagnetic magnetic resonance imaging (MRI) contrast enhancer. Introduced in 1981, it has been used to assist imaging of blood vessels and the surrounding tissue by injection into the desired tissue. It is often used when viewing intracranial lesions with abnormal vascularity or abnormalities in the blood-brain barrier. Gd-DTPA is a gadolinium complex of diethylenetriamine pentaacetic acid with ionic paramagnetic properties.

[edit] References


Pills  This pharmacology-related article is a stub. You can help Wikipedia by expanding it.
Retrieved from "http://en.wikipedia.org../../../g/a/d/Gadopentetate_dimeglumine.html"